MENLO PARK, Calif. & ALAMEDA, Calif.-- --Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc. that is developing clinical-stage stem cell therapeutic assets acquired from Geron Corporation, today announced the launch of its new website, http://ift.tt/1mXLgNN .
http://ift.tt/1i3XIGF
http://ift.tt/1i3XIGF
No comments:
Post a Comment